Q3 2024 · 13F-HR
BRAIDWELL LPholdings as filed
Filed 2024-11-14 · accession 0001920938-24-000006
$3.53B
Reported value
81
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 40131MAB5 | GH 0 11/15/27 | GUARDANT HEALTH INC | $216.0M | 6.12% | 268,252,000 | Common | SOLE |
| 10806XAB8 | BBIO 2.5 03/15/27 | BRIDGEBIO PHARMA INC | $145.6M | 4.13% | 140,838,000 | Common | SOLE |
| 67011XAB9 | NVCR 0 11/01/25 | NOVOCURE LTD | $133.3M | 3.78% | 140,834,000 | Common | SOLE |
| 156944100 | CGON | CG ONCOLOGY INC | $119.6M | 3.39% | 3,170,875 | Common | SOLE |
| 670704AJ4 | GMED 0.375 03/15/25 | NUVASIVE INC | $111.9M | 3.17% | 114,206,000 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $106.6M | 3.02% | 2,707,255 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $105.7M | 3.00% | 917,674 | Common | SOLE |
| 64049MAB6 | NEO 0.25 01/15/28 | NEOGENOMICS INC | $96.9M | 2.75% | 116,381,000 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $96.5M | 2.74% | 1,643,226 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $90.1M | 2.55% | 3,125,183 | Common | SOLE |
| 46333XAH1 | IRWD 1.5 06/15/26 | IRONWOOD PHARMACEUTICALS INC | $82.5M | 2.34% | 92,740,000 | Common | SOLE |
| 252131AM9 | DXCM 0.375 05/15/28 | DEXCOM INC | $82.3M | 2.33% | 92,700,000 | Common | SOLE |
| 016255101 | ALGN | ALIGN TECHNOLOGY INC | $79.3M | 2.25% | 311,679 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH INC | $76.7M | 2.17% | 3,342,124 | Common | SOLE |
| 45784PAK7 | PODD 0.375 09/01/26 | INSULET CORP | $76.4M | 2.17% | 63,800,000 | Common | SOLE |
| 52490G102 | LEGN | LEGEND BIOTECH CORP | $75.1M | 2.13% | 1,541,551 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $73.2M | 2.08% | 1,156,977 | Common | SOLE |
| G52694109 | KNSA | KINIKSA PHARMACEUTICALS INTL | $72.3M | 2.05% | 2,894,513 | Common | SOLE |
| 70975L107 | PEN | PENUMBRA INC | $70.2M | 1.99% | 361,428 | Common | SOLE |
| 252131AK3 | DXCM 0.25 11/15/25 | DEXCOM INC | $70.1M | 1.99% | 73,500,000 | Common | SOLE |
| 56600D107 | MRVI | MARAVAI LIFESCIENCES HLDGS I | $69.4M | 1.97% | 8,353,287 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $67.9M | 1.92% | 4,873,853 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $64.4M | 1.83% | 2,189,836 | Common | SOLE |
| 759916109 | RGEN | REPLIGEN CORP | $59.0M | 1.67% | 396,781 | Common | SOLE |
| 450056106 | IRTC | IRHYTHM TECHNOLOGIES INC | $58.1M | 1.65% | 782,557 | Common | SOLE |
| 761299AB2 | TVTX 2.5 09/15/25 | TRAVERE THERAPEUTICS INC | $53.5M | 1.52% | 56,031,000 | Common | SOLE |
| 02081GAB8 | ATEC 0.75 08/01/26 | ALPHATEC HLDGS INC | $52.5M | 1.49% | 58,217,000 | Common | SOLE |
| 04016X101 | ARGX | ARGENX SE | $52.4M | 1.49% | 96,724 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $52.3M | 1.48% | 1,958,310 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $50.4M | 1.43% | 238,911 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $46.3M | 1.31% | 370,400 | Common | SOLE |
| 10806XAD4 | BBIO 2.25 02/01/29 | BRIDGEBIO PHARMA INC | $45.0M | 1.28% | 53,594,000 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $44.9M | 1.27% | 91,300 | Common | SOLE |
| G29687103 | AVDL | AVADEL PHARMACEUTICALS PLC | $44.4M | 1.26% | 3,388,939 | Common | SOLE |
| 055477103 | BCAX | BICARA THERAPEUTICS INC | $42.2M | 1.20% | 1,657,600 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $41.1M | 1.16% | 707,240 | Common | SOLE |
| 377322102 | GKOS | GLAUKOS CORP | $40.6M | 1.15% | 311,616 | Common | SOLE |
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $39.0M | 1.11% | 183,818 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $34.0M | 0.96% | 297,568 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $33.7M | 0.95% | 3,070,837 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $31.6M | 0.90% | 1,284,472 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $30.7M | 0.87% | 168,691 | Common | SOLE |
| 68752L100 | KIDS | ORTHOPEDIATRICS CORP | $30.0M | 0.85% | 1,107,770 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $29.6M | 0.84% | 441,086 | Common | SOLE |
| 09075V102 | BNTX | BIONTECH SE | $29.4M | 0.83% | 247,750 | Common | SOLE |
| 69913P105 | FNAUSD | PARAGON 28 INC | $27.6M | 0.78% | 4,135,109 | Common | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $24.8M | 0.70% | 3,499,427 | Common | SOLE |
| 02081G201 | ATEC | ALPHATEC HLDGS INC | $22.5M | 0.64% | 4,041,065 | Common | SOLE |
| 415858109 | HROW | HARROW INC | $19.8M | 0.56% | 439,638 | Common | SOLE |
| 230031106 | CGEM | CULLINAN THERAPEUTICS INC | $19.7M | 0.56% | 1,176,173 | Common | SOLE |
| 03209RAB9 | AMPH 2 03/15/29 | AMPHASTAR PHARMACEUTICALS IN | $19.5M | 0.55% | 18,400,000 | Common | SOLE |
| 30063P105 | EXK | EXACT SCIENCES CORP | $19.5M | 0.55% | 286,178 | Common | SOLE |
| 67576A100 | OCUL | OCULAR THERAPEUTIX INC | $19.5M | 0.55% | 2,239,770 | Common | SOLE |
| N44445109 | IMTX | IMMATICS N.V | $18.8M | 0.53% | 1,647,565 | Common | SOLE |
| 46333X108 | IRWD | IRONWOOD PHARMACEUTICALS INC | $18.3M | 0.52% | 4,438,232 | Common | SOLE |
| 101137107 | BSX | BOSTON SCIENTIFIC CORP | $15.9M | 0.45% | 189,200 | Common | SOLE |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $13.5M | 0.38% | 493,687 | Common | SOLE |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $13.2M | 0.38% | 1,225,448 | Common | SOLE |
| 15102K100 | CELC | CELCUITY INC | $13.2M | 0.37% | 884,306 | Common | SOLE |
| 687604108 | ORKA | ORUKA THERAPEUTICS INC | $12.6M | 0.36% | 515,726 | Common | SOLE |
| 405024AB6 | HAE 0 03/01/26 | HAEMONETICS CORP MASS | $10.6M | 0.30% | 11,500,000 | Common | SOLE |
| 014442107 | ALEC | ALECTOR INC | $10.1M | 0.29% | 2,158,245 | Common | SOLE |
| G9TY5A101 | ZURA | ZURA BIO LTD | $10.0M | 0.28% | 2,472,806 | Common | SOLE |
| 45784P101 | PODD | INSULET CORP | $9.9M | 0.28% | 42,500 | Common | SOLE |
| 64157F103 | NVROEUR | NEVRO CORP | $9.5M | 0.27% | 1,698,768 | Common | SOLE |
| 14843C105 | CSTL | CASTLE BIOSCIENCES INC | $9.5M | 0.27% | 331,986 | Common | SOLE |
| 98401F105 | XNCR | XENCOR INC | $9.4M | 0.27% | 466,448 | Common | SOLE |
| 471871202 | JSPR | JASPER THERAPEUTICS INC | $9.1M | 0.26% | 483,300 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $7.6M | 0.22% | 298,400 | Common | SOLE |
| 52886X107 | LXEO | LEXEO THERAPEUTICS INC | $6.6M | 0.19% | 728,777 | Common | SOLE |
| 745848101 | LUNG | PULMONX CORP | $6.2M | 0.18% | 752,541 | Common | SOLE |
| 88331L108 | SKIN | THE BEAUTY HEALTH COMPANY | $5.8M | 0.17% | 4,049,694 | Common | SOLE |
| 232109AG3 | — | CUTERA INC | $5.0M | 0.14% | 29,000,000 | Common | SOLE |
| 232109AD0 | — | CUTERA INC | $4.0M | 0.11% | 25,240,000 | Common | SOLE |
| 359616109 | FULC | FULCRUM THERAPEUTICS INC | $3.8M | 0.11% | 1,069,158 | Common | SOLE |
| 92539P101 | — | VERVE THERAPEUTICS INC | $3.0M | 0.09% | 623,980 | Common | SOLE |
| 462260100 | IOVA | IOVANCE BIOTHERAPEUTICS INC | $2.0M | 0.06% | 217,928 | Common | SOLE |
| 43157M102 | — | HILLEVAX INC | $1.9M | 0.05% | 1,064,000 | Common | SOLE |
| 528872302 | LXRX | LEXICON PHARMACEUTICALS INC | $1.3M | 0.04% | 801,584 | Common | SOLE |
| 23306J200 | — | DBV TECHNOLOGIES S A | $1.1M | 0.03% | 1,630,542 | Common | SOLE |
| 28623U101 | — | ELEVATION ONCOLOGY INC | $284,054 | 0.01% | 473,503 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.